BPC-157 10mg

Product Background

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a partial sequence of a protective protein originally identified in human gastric juice. It was first characterized in the early 1990s by Dr. Predrag Sikirić and colleagues at the University of Zagreb in Croatia, who have published over 100 preclinical studies investigating the compound. Unlike many peptides, BPC-157 has demonstrated stability in gastric acid in laboratory conditions, which has made it a compound of interest for gastrointestinal and systemic research. Investigations have explored its effects on a variety of tissue systems including muscle, tendon, ligament, bone, vascular endothelium, and the nervous system in rodent models.

About the Product

Each vial contains 10 mg of BPC-157 supplied as a lyophilized white powder at ≥99% purity, with 10 vials per package. The 10mg vial format is the standard size for most laboratory research protocols and is intended for reconstitution with bacteriostatic or sterile water prior to any in vitro or preclinical application.

Applications

• Gastrointestinal tract research, including studies of mucosal protection and inflammatory bowel models
• Tendon and ligament repair studies in rodent injury models
• Wound healing and angiogenesis research
• Musculoskeletal recovery studies following induced injury
• Neuroprotection research, including investigations of central and peripheral nervous system models
• Studies of nitric oxide signaling and vascular endothelial function
• Research on bone fracture healing and osteoblast activity